These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 7543432

  • 1. The significance of immunoglobulin M antibody response to hepatitis C virus core protein in patients with chronic hepatitis C.
    Yuki N, Hayashi N, Ohkawa K, Hagiwara H, Oshita M, Katayama K, Sasaki Y, Kasahara A, Fusamoto H, Kamada T.
    Hepatology; 1995 Aug; 22(2):402-6. PubMed ID: 7543432
    [Abstract] [Full Text] [Related]

  • 2. Significance of serum immunoglobulin M to hepatitis C virus core in patients with chronic hepatitis C.
    Tran A, Yang G, Dreyfus G, Rouquié P, Durant J, Rampal A, Rampal P, Benzaken S.
    Am J Gastroenterol; 1997 Oct; 92(10):1835-8. PubMed ID: 9382047
    [Abstract] [Full Text] [Related]

  • 3. Immunoglobulin M antibody to hepatitis C virus core antigen: correlations with viral replication, histological activity, and liver disease outcome.
    Quiroga JA, van Binsbergen J, Wang CY, Pardo M, Navas S, Trines C, Herrero M, Carreño V.
    Hepatology; 1995 Dec; 22(6):1635-40. PubMed ID: 7489967
    [Abstract] [Full Text] [Related]

  • 4. Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection.
    Yuki N, Hayashi N, Kasahara A, Hagiwara H, Mita E, Ohkawa K, Katayama K, Fusamoto H, Kamada T.
    Hepatology; 1996 May; 23(5):947-52. PubMed ID: 8621173
    [Abstract] [Full Text] [Related]

  • 5. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy.
    Yuki N, Hayashi N, Hagiwara H, Takehara T, Katayama K, Kasahara A, Fusamoto H, Kamada T.
    Hepatology; 1993 Jun; 17(6):960-5. PubMed ID: 7685734
    [Abstract] [Full Text] [Related]

  • 6. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
    Negro F, Giostra E, Rubbia-Brandt L, Mentha G, Colucci G, Morel P, Quadri R, Perrin L, Hadengue A.
    J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
    [Abstract] [Full Text] [Related]

  • 7. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
    Pawlotsky JM, Pellerin M, Bouvier M, Roudot-Thoraval F, Germanidis G, Bastie A, Darthuy F, Rémiré J, Soussy CJ, Dhumeaux D.
    J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.
    Crespo J, Carte B, Lozano JL, Casafont F, Rivero M, de la Cruz F, Pons-Romero F.
    Am J Gastroenterol; 1997 Sep; 92(9):1458-62. PubMed ID: 9317062
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis C virus replication and antibody responses toward specific hepatitis C virus proteins.
    Yuki N, Hayashi N, Kasahara A, Hagiwara H, Ohkawa K, Fusamoto H, Kamada T.
    Hepatology; 1994 Jun; 19(6):1360-5. PubMed ID: 7514560
    [Abstract] [Full Text] [Related]

  • 10. Identification of serologically silent occult hepatitis C virus infection by detecting immunoglobulin G antibody to a dominant HCV core peptide epitope.
    Quiroga JA, Castillo I, Llorente S, Bartolomé J, Barril G, Carreño V.
    J Hepatol; 2009 Feb; 50(2):256-63. PubMed ID: 19070391
    [Abstract] [Full Text] [Related]

  • 11. IgG and IgM core antibodies and viral replication in hepatitis C virus carriers.
    Yuki N, Hayashi N, Hagiwara H, Naito M, Ohkawa K, Katayama K, Kasahara A, Fusamoto H, Kamada T.
    J Hepatol; 1994 Jul; 21(1):110-4. PubMed ID: 7525692
    [Abstract] [Full Text] [Related]

  • 12. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections.
    Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, Schianchi C, Missale G, Marin MG, Fiaccadori F.
    Hepatology; 1994 Feb; 19(2):286-95. PubMed ID: 8294086
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA.
    Tanaka E, Ohue C, Aoyagi K, Yamaguchi K, Yagi S, Kiyosawa K, Alter HJ.
    Hepatology; 2000 Aug; 32(2):388-93. PubMed ID: 10915747
    [Abstract] [Full Text] [Related]

  • 14. Anti-hepatitis C virus immunoglobulin M antibody in patients with chronic hepatitis type C.
    Kikuchi T, Onji M, Michitaka K, Ohta Y.
    Hepatogastroenterology; 1992 Dec; 39(6):525-8. PubMed ID: 1336473
    [Abstract] [Full Text] [Related]

  • 15. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease].
    Sakashita H.
    Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128
    [Abstract] [Full Text] [Related]

  • 16. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
    Pawlotsky JM, Darthuy F, Rémiré J, Pellet C, Udin L, Stuyver L, Roudot-Thoraval F, Duvoux C, Douvin C, Mallat A.
    J Med Virol; 1995 Nov; 47(3):285-91. PubMed ID: 8551282
    [Abstract] [Full Text] [Related]

  • 17. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M, Penning M, van Putten M, Lukashov V, van den Hoek A, McMorrow M, Goudsmit J.
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [Abstract] [Full Text] [Related]

  • 18. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
    Cerino A, Bissolati M, Cividini A, Nicosia A, Esumi M, Hayashi N, Mizuno K, Slobbe R, Oudshoorn P, Silini E, Asti M, Mondelli MU.
    J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
    [Abstract] [Full Text] [Related]

  • 19. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction.
    Lau GK, Davis GL, Wu SP, Gish RG, Balart LA, Lau JY.
    Hepatology; 1996 Jun; 23(6):1318-23. PubMed ID: 8675145
    [Abstract] [Full Text] [Related]

  • 20. Clinical importance of assessment of anti-HCV IgM antibodies in chronic hepatitis C.
    Stránský J, Honzáková E, Vandasová J, Horejsová M, Kyncl J, Nĕmecek V, Horák J.
    Acta Virol; 1996 Apr; 40(2):61-5. PubMed ID: 8886113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.